APA

Turnbull C., Loveday C., Izatt L. & Ellard S. (20190506). Response to Letter to the Editor: "p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer". : The Journal of clinical endocrinology and metabolism.

Chicago

Turnbull Clare, Loveday Chey, Izatt Louise and Ellard Sian. 20190506. Response to Letter to the Editor: "p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer". : The Journal of clinical endocrinology and metabolism.

Harvard

Turnbull C., Loveday C., Izatt L. and Ellard S. (20190506). Response to Letter to the Editor: "p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer". : The Journal of clinical endocrinology and metabolism.

MLA

Turnbull Clare, Loveday Chey, Izatt Louise and Ellard Sian. Response to Letter to the Editor: "p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer". : The Journal of clinical endocrinology and metabolism. 20190506.